GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » Capex-to-Operating-Cash-Flow

Medclair AB (NGM:MCLR) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medclair AB Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Medclair AB's Capital Expenditure for the three months ended in Mar. 2024 was kr0.00 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was kr0.71 Mil.

Hence, Medclair AB's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 0.00.


Medclair AB Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Medclair AB's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB Capex-to-Operating-Cash-Flow Chart

Medclair AB Annual Data
Trend Apr15 Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - 0.77 - - 1.04

Medclair AB Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medclair AB's Capex-to-Operating-Cash-Flow

For the Medical Devices subindustry, Medclair AB's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medclair AB's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medclair AB's Capex-to-Operating-Cash-Flow falls into.



Medclair AB Capex-to-Operating-Cash-Flow Calculation

Medclair AB's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-5.454) / 5.261
=1.04

Medclair AB's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 0.711
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medclair AB  (NGM:MCLR) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Medclair AB Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medclair AB's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medclair AB (NGM:MCLR) Business Description

Traded in Other Exchanges
N/A
Address
Box 3113, Stockholm, SWE, 103 62
Medclair Invest AB is a research and development company with leading-edge expertise in measurement, collection and destruction of Nitrous Oxide. The customers are found in a number of industries such as Obstetrics, Pediatrics, Emergency departments and Dental Care facilities. The business is operational on a global scale.

Medclair AB (NGM:MCLR) Headlines

No Headlines